Market Cap 10.91M
Revenue (ttm) 0.00
Net Income (ttm) -5.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 217,117
Avg Vol 130,044
Day's Range N/A - N/A
Shares Out 21.41M
Stochastic %K 3%
Beta 1.51
Analysts Strong Sell
Price Target $8.00

Company Profile

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The company develops KROS 101, an orally available glucocorticoid-induced tumor necrosis factor receptor (GITR) ligand small-molecule antagonist to deplete regulatory T cells (Tregs) and activate effector T cells to augment the antitumor immune respons...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 948 2356
Address:
2355 Westwood Boulevard, Suite 139, Los Angeles, United States
Oldshoe
Oldshoe Jun. 1 at 4:57 PM
$KAPA What I expect. 1- The next few weeks continue to be low volume. 2- Roughly around same time as s/h voting materials are issued (estimate mid-June), expecting another PR about 'partnership' with Celyn/CL-273 (mild catalyst, sustains mild mkt interest). 3- Within a week before (or during) annual meeting, news about NSCLC phase 1 safety & interim efficacy (moderate catalyst, some price rise to form new level). 4- Price likely to mostly sustain at the new level through expected r/s occurring July/Aug - that time frame coincides with start of likely run-up to p2 prostate cancer trial efficacy update that the company has announced will be released Q3 (significant catalyst good or bad; note that good safety & efficacy was indicated in p1). 5- Final trial data for phase 2 prostate cancer trial expected to be released 1Q2027 (mid/late March release most likely). All that is ONLY my opinion at this time - I could be quite wrong - not financial advice in any way.
1 · Reply
TraderBuckNKY
TraderBuckNKY Jun. 1 at 3:45 PM
$KAPA ...hopefully the Kool-Aid is completely dried up and we can all sell at a loss and move on...other sectors are screaming while we have continued to sip and sigh and hope. "management" has either horribly mis-managed or; lied, deceived, fabricated and concocted a twisted tale of deception and a flossing of the US retail investor. We've seen this story play out before many times...and, is it possible that ICE/certain government agencies are challenging the Work Visas of several key management personnel... ?
0 · Reply
TB85
TB85 May. 29 at 5:21 PM
$KAPA I dont remeber dates and such! But, is there any risk of an RS in kapa any time soon?? I mean, ive been watching it from the bench, before i got in again. And the lack of updates and any kind of news, seems still to be a major problem to "stimulate" the sp.👀
1 · Reply
TraderBuckNKY
TraderBuckNKY May. 29 at 2:45 PM
0 · Reply
Oldshoe
Oldshoe May. 27 at 4:30 PM
0 · Reply
Turkialharbi70
Turkialharbi70 May. 26 at 1:14 PM
0 · Reply
uptrend2025
uptrend2025 May. 22 at 2:19 PM
$KAPA Data and Partnership News next week?
0 · Reply
ezcheezie
ezcheezie May. 21 at 8:25 PM
$KAPA Interesting my comment got deleted for some reason.
1 · Reply
uptrend2025
uptrend2025 May. 21 at 8:02 PM
$KAPA 🚀 🚀
1 · Reply
Oldshoe
Oldshoe May. 21 at 7:30 PM
$KAPA Anybody got any rocket emojis handy?
0 · Reply
Latest News on KAPA
Kairos Pharma Proxy statement: Proxy filing

May 26, 2026, 8:00 AM EDT - 8 days ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 12 days ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Slides: Investor presentation

May 15, 2026, 7:00 AM EDT - 19 days ago

Kairos Pharma Slides: Investor presentation


Kairos Pharma Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 21 days ago

Kairos Pharma Quarterly report: Q1 2026


Kairos Pharma, Ltd. to Present at the LD Micro Invitational XVI

May 13, 2026, 5:30 AM EDT - 21 days ago

Kairos Pharma, Ltd. to Present at the LD Micro Invitational XVI


Kairos Pharma Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 23 days ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 2 months ago

Kairos Pharma Annual report: Q4 2025


Kairos Pharma to acquire CL-273 from Celyn Therapeutics

2026-03-02T11:53:03.000Z - 3 months ago

Kairos Pharma to acquire CL-273 from Celyn Therapeutics


Kairos Pharma Registration statement: Registration Filing

Jan 13, 2026, 7:00 AM EST - 5 months ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma files $75M mixed securities shelf

2026-01-13T11:05:46.000Z - 5 months ago

Kairos Pharma files $75M mixed securities shelf


Kairos Pharma Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 7 months ago

Kairos Pharma Quarterly report: Q3 2025


Kairos Pharma Provides Shareholder Update

Nov 4, 2025, 8:00 AM EST - 7 months ago

Kairos Pharma Provides Shareholder Update


Kairos Pharma Transcript: Study Update

Sep 18, 2025, 5:00 PM EDT - 9 months ago

Kairos Pharma Transcript: Study Update


Kairos Pharma Press release: Study Update

Sep 18, 2025, 5:00 PM EDT - 9 months ago

Kairos Pharma Press release: Study Update


Kairos Pharma announces interim efficacy analysis of ENV105

2025-09-18T12:16:01.000Z - 9 months ago

Kairos Pharma announces interim efficacy analysis of ENV105


Kairos Pharma Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 10 months ago

Kairos Pharma Quarterly report: Q2 2025


Kairos Pharma management to meet with Maxim

2025-08-04T14:05:21.000Z - 10 months ago

Kairos Pharma management to meet with Maxim


Why Is Kairos Pharma Stock (KAPA) Up 170% Today?

2025-07-16T01:26:00.000Z - 11 months ago

Why Is Kairos Pharma Stock (KAPA) Up 170% Today?


Kairos Pharma Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma, Ltd. Announces Participation in the D.

May 6, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma, Ltd. Announces Participation in the D.


Kairos Pharma Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma Proxy statement: Proxy Filing

May 1, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma Ltd. Provides Letter to Stockholders

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Ltd. Provides Letter to Stockholders


Kairos Pharma Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Annual report: Q4 2024

Apr 14, 2025, 6:00 PM EDT - 1 year ago

Kairos Pharma Annual report: Q4 2024


Kairos Pharma initiated with a Buy at H.C. Wainwright

2025-04-03T10:16:23.000Z - 1 year ago

Kairos Pharma initiated with a Buy at H.C. Wainwright


Kairos Pharma completes safety lead-in of ENV105 trial

2025-03-31T11:11:12.000Z - 1 year ago

Kairos Pharma completes safety lead-in of ENV105 trial


Kairos Pharma initiated with a Buy at Maxim

2025-03-27T11:40:11.000Z - 1 year ago

Kairos Pharma initiated with a Buy at Maxim


Kairos Pharma announces new DoD funding for ENV205 research

2025-02-18T13:42:31.000Z - 1 year ago

Kairos Pharma announces new DoD funding for ENV205 research


Kairos Pharma Registration statement: Registration Filing

Jan 29, 2025, 7:00 AM EST - 1 year ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Provides Business Update and Outlook into 2025

Jan 21, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Provides Business Update and Outlook into 2025


Kairos Pharma Ltd trading resumes

2025-01-14T15:00:26.000Z - 1 year ago

Kairos Pharma Ltd trading resumes


IBN Initiates Coverage of Kairos Pharma Ltd.

Nov 26, 2024, 8:30 AM EST - 1 year ago

IBN Initiates Coverage of Kairos Pharma Ltd.


Kairos Pharma Quarterly report: Q3 2024

Nov 13, 2024, 6:00 PM EST - 1 year ago

Kairos Pharma Quarterly report: Q3 2024


Kairos Pharma Earnings release: Q3 2024

Nov 13, 2024, 6:00 PM EST - 1 year ago

Kairos Pharma Earnings release: Q3 2024


Kairos Pharma to Present at the LD Micro Main Event XVII

Oct 22, 2024, 9:00 AM EDT - 1 year ago

Kairos Pharma to Present at the LD Micro Main Event XVII


Kairos Pharma Closing of $6.2 Million Initial Public Offering

Sep 17, 2024, 4:29 PM EDT - 1 year ago

Kairos Pharma Closing of $6.2 Million Initial Public Offering


Kairos Pharma Prices $6.2 Million Initial Public Offering

Sep 16, 2024, 10:49 AM EDT - 1 year ago

Kairos Pharma Prices $6.2 Million Initial Public Offering


Kairos Pharma Registration statement: Registration Filing

Aug 16, 2024, 8:00 AM EDT - 1 year ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

Jun 4, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 20, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 13, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 1, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma to sell 1.55 million shares in IPO at $4 each

Feb 14, 2024, 6:16 PM EST - 2 years ago

Kairos Pharma to sell 1.55 million shares in IPO at $4 each


Oldshoe
Oldshoe Jun. 1 at 4:57 PM
$KAPA What I expect. 1- The next few weeks continue to be low volume. 2- Roughly around same time as s/h voting materials are issued (estimate mid-June), expecting another PR about 'partnership' with Celyn/CL-273 (mild catalyst, sustains mild mkt interest). 3- Within a week before (or during) annual meeting, news about NSCLC phase 1 safety & interim efficacy (moderate catalyst, some price rise to form new level). 4- Price likely to mostly sustain at the new level through expected r/s occurring July/Aug - that time frame coincides with start of likely run-up to p2 prostate cancer trial efficacy update that the company has announced will be released Q3 (significant catalyst good or bad; note that good safety & efficacy was indicated in p1). 5- Final trial data for phase 2 prostate cancer trial expected to be released 1Q2027 (mid/late March release most likely). All that is ONLY my opinion at this time - I could be quite wrong - not financial advice in any way.
1 · Reply
TraderBuckNKY
TraderBuckNKY Jun. 1 at 3:45 PM
$KAPA ...hopefully the Kool-Aid is completely dried up and we can all sell at a loss and move on...other sectors are screaming while we have continued to sip and sigh and hope. "management" has either horribly mis-managed or; lied, deceived, fabricated and concocted a twisted tale of deception and a flossing of the US retail investor. We've seen this story play out before many times...and, is it possible that ICE/certain government agencies are challenging the Work Visas of several key management personnel... ?
0 · Reply
TB85
TB85 May. 29 at 5:21 PM
$KAPA I dont remeber dates and such! But, is there any risk of an RS in kapa any time soon?? I mean, ive been watching it from the bench, before i got in again. And the lack of updates and any kind of news, seems still to be a major problem to "stimulate" the sp.👀
1 · Reply
TraderBuckNKY
TraderBuckNKY May. 29 at 2:45 PM
0 · Reply
Oldshoe
Oldshoe May. 27 at 4:30 PM
0 · Reply
Turkialharbi70
Turkialharbi70 May. 26 at 1:14 PM
0 · Reply
uptrend2025
uptrend2025 May. 22 at 2:19 PM
$KAPA Data and Partnership News next week?
0 · Reply
ezcheezie
ezcheezie May. 21 at 8:25 PM
$KAPA Interesting my comment got deleted for some reason.
1 · Reply
uptrend2025
uptrend2025 May. 21 at 8:02 PM
$KAPA 🚀 🚀
1 · Reply
Oldshoe
Oldshoe May. 21 at 7:30 PM
$KAPA Anybody got any rocket emojis handy?
0 · Reply
ezcheezie
ezcheezie May. 21 at 5:46 PM
$KAPA Slowly climbing back up, not much resistance. Very nice to see. Looks like solid support at .49. Need news and some volume and this will soar.
1 · Reply
KingJames_
KingJames_ May. 21 at 1:51 PM
$KAPA I love this company.... the amazing science and potential for a real breakout is all here.
0 · Reply
uptrend2025
uptrend2025 May. 20 at 8:02 PM
$KAPA At least it closed above $0.50. Some progress.
1 · Reply
TB85
TB85 May. 20 at 2:52 PM
$KAPA Been away for a while, making money on other places, bringing profits back here. Yes, this is a true sleeper, but couldn't leave kapa forever, because the have a great thing going on. So, what are we waiting for near term, any kind soul in here could give a short update!??🙏 Thanks.
0 · Reply
Oldshoe
Oldshoe May. 20 at 2:48 PM
$KAPA Watch for inflow at a 0.52 break
0 · Reply
Oldshoe
Oldshoe May. 20 at 2:40 PM
$KAPA Need a 0.52 break for bullish momentum here
1 · Reply
Oldshoe
Oldshoe May. 20 at 2:21 PM
$KAPA That 30k greèn candle at the 0.50 adds good color
1 · Reply
uptrend2025
uptrend2025 May. 19 at 6:04 PM
$KAPA Don’t be a pooper close above $0.50 today por favor.
0 · Reply
uptrend2025
uptrend2025 May. 19 at 4:26 PM
$KAPA When Partnership News? I want $2
1 · Reply
ezcheezie
ezcheezie May. 19 at 2:20 PM
$KAPA Buy now
0 · Reply
Oldshoe
Oldshoe May. 19 at 1:39 PM
$KAPA Buy now
0 · Reply
Xtracked
Xtracked May. 19 at 1:32 PM
$KAPA 1/2 million shares already. Ya.....It's coming
0 · Reply